Potential Link Between Proprotein Convertase Subtilisin/Kexin Type 9 and Alzheimer's Disease
Volume 1 ; Issue 1 ; in Month : Jan-Mar (2018) Article No : 106
Oldham CE, Powell RS, Williams AB, Dixon S, Wooten
Alzheimer's disease [AD] is not only the most common neurodegenerative disease but is also currently incurable. Proprotein convertase subtilisin/kexin-9 [PCSK9] is an indirect regulator of plasma low density lipoprotein [LDL] levels controlling LDL receptor expression at the plasma membrane. PCSK9 also appears to regulate the development of glucose intolerance, insulin resistance, abdominal obesity, inflammation, and hypertension, conditions that have been identified as risk factors for AD. PCSK9 levels also depend on age, sex, and ethnic background, factors associated with AD. Herein, we will review indirect evidence that suggests a link between PCSK9 levels and AD.
Full Text Attachment
Views : 18 Downloads : 6